Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 96

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 96
---
 on us or our directors or have any of them appear in a U.S. court.

We understand that in England
it may not be possible to bring proceedings or enforce a judgment of a U.S. court in respect of civil liabilities based solely on the
federal securities laws of the United States. In addition, awards of punitive damages in actions brought in the United States or elsewhere
may be unenforceable in England. An award of damages is usually considered to be punitive if it does not seek to compensate the claimant
for loss or damage suffered and is instead intended to punish the defendant. In addition to public policy aspects of enforcement, such
as the aforementioned, the enforceability of any judgment in England will depend on the particular facts of the case and the relevant
circumstances, for example (and expressly without limitation), whether there are any relevant insolvency proceedings which may affect
the ability to enforce a judgment. In addition, the United States and the United Kingdom have not currently entered into a treaty (or
convention) providing for the reciprocal recognition and enforcement of judgments (although both are contracting states to the New York
Convention on the Recognition and Enforcement of Foreign Arbitral Awards).

We have appointed Donald
J. Puglisi of Puglisi & Associates as our authorized agent upon whom process may be served in any action instituted in any U.S. federal
or state court having subject matter jurisdiction arising out of or based upon the securities offered by this prospectus.

<div align='center'>EXPENSES OF THE OFFERING</div>

The following table sets
forth the expenses payable by us in connection with the sale and distribution of the securities being registered hereby. All amounts shown,
other than the SEC registration fee, are estimates:

| SEC registration fee |     | $ |    568 |
| Printing             
 and engraving        |     | $ |  5,000 |
| Accounting           
 services             |     | $ | 15,000 |
| Legal                
 fees and expenses    |     | $ | 50,000 |
| Miscellaneous        |     | $ |  5,000 |
| Total                |     | $ | 75,568 |

| 50 |

<div align='center'>, 2025</div>

| 51 |

<div align='center'>PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

| Item 6. | Indemnification of Directors and Officers. |

The Registrant’s articles
of association